Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and quality of life in Chinese patients with ocular myasthenia gravis
Ting Tang, Qiwen Feng, Youran Cai, Yuying Dong, Jian Chen, Rijia Zhang, Qing Zhou · 2026
Read Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and quality of life in Chinese patients with ocular myasthenia gravis by Ting Tang, Qiwen Feng, Youran Cai, Yuying Dong, Jian Chen, Rijia Zhang, Qing Zhou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13238584.txt.
Description
Ting Tang and colleagues validated two rating tools in 2026 for Chinese patients with ocular myasthenia gravis, a weakness disorder confined to the eye muscles. Fifty-two patients at one hospital completed the OMGRate severity scale and the MG-QOL15 quality-of-life questionnaire before treatment and at one, three, and six months afterward. A clinical grading scale provided comparison.
All scores fell steadily with treatment and reached their best levels at six months. The two OMGRate parts correlated with each other and with quality-of-life scores throughout, and with clinical grades after treatment. Age at onset and first symptoms shaped quality of life strongly. The authors conclude the OMGRate works for severity assessment in this population, and that symptom relief and lived improvement move together.
Catalog record
| CREATOR | Ting Tang, Qiwen Feng, Youran Cai, Yuying Dong, Jian Chen, Rijia Zhang, Qing Zhou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |